Advancing Healthcare with Prescription Digital Therapeutics : Episode 4

Assessing the Cost-Effectiveness of Prescription Digital Therapeutics

April 16, 2024

Opinion

Video

Mahsa Salsabili, PharmD, PhD, underscores the potential cost-effectiveness of treatment through the adoption of prescription digital therapeutics, while acknowledging that additional evidence is required to conclusively determine their cost-effectiveness.

EP: 1.Overview of Prescription Digital Therapeutics and Impact on Clinical Practice

EP: 2.Bridging Care Gaps with Prescription Digital Therapeutics

EP: 3.Harnessing Prescription Drug Therapeutics as Monotherapy and Adjunct Therapy

Now Viewing

EP: 4.Assessing the Cost-Effectiveness of Prescription Digital Therapeutics

EP: 5.FDA Approval Pathway for Prescription Digital Therapeutics

EP: 6.Navigating Insurance Coverage for Prescription Digital Therapeutics

EP: 7.Prescribing Prescription Drug Therapeutics: Factors for Providers and Payers to Consider

EP: 8.Risk and Value-Based Contracting for Prescription Drug Therapeutics and Manufacturer’s Support in Utilization

EP: 9.PDTs Represent a Shift in How Treatment Is Delivered

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!